These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 24852956)

  • 1. Long-term control of carbapenemase-producing Enterobacteriaceae at the scale of a large French multihospital institution: a nine-year experience, France, 2004 to 2012.
    Fournier S; Monteil C; Lepainteur M; Richard C; Brun-Buisson C; Jarlier V; Ap-Hp Outbreaks Control Group C
    Euro Surveill; 2014 May; 19(19):. PubMed ID: 24852956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Link between carbapenemase-producing Enterobacteria carriage and cross-border exchanges: eight-year surveillance in a large French multihospitals institution.
    Fournier S; Lepainteur M; Kassis-Chikhani N; Huang M; Brun-Buisson C; Jarlier V;
    J Travel Med; 2012; 19(5):320-3. PubMed ID: 22943275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficiency of different control measures for preventing carbapenemase-producing enterobacteria and glycopeptide-resistant
    Fournier S; Desenfant L; Monteil C; Nion-Huang M; Richard C; Jarlier V;
    Euro Surveill; 2018 Feb; 23(8):. PubMed ID: 29486831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term control of vancomycin-resistant Enterococcus faecium at the scale of a large multihospital institution: a seven-year experience.
    Fournier S; Brossier F; Fortineau N; Gillaizeau F; Akpabie A; Aubry A; Barbut F; Chedhomme FX; Kassis-Chikhani N; Lucet JC; Robert J; Seytre D; Simon I; Vanjak D; Zahar JR; Brun-Buisson C; Jarlier V
    Euro Surveill; 2012 Jul; 17(30):. PubMed ID: 22856512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control strategies for carbapenemase-producing Enterobacteriaceae at different levels of the healthcare system.
    Asensio Á; Cantero M; Shaw E; Vergara-López S
    Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():61-6. PubMed ID: 25542054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is cohorting the only solution to control carbapenemase-producing Enterobacteriaceae outbreaks? A single-centre experience.
    Legeay C; Thépot-Seegers V; Pailhoriès H; Hilliquin D; Zahar JR
    J Hosp Infect; 2018 Aug; 99(4):390-395. PubMed ID: 29438727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of carbapenemase-producing Enterobacteriaceae outbreaks in acute settings: an evidence review.
    French CE; Coope C; Conway L; Higgins JP; McCulloch J; Okoli G; Patel BC; Oliver I
    J Hosp Infect; 2017 Jan; 95(1):3-45. PubMed ID: 27890334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of simultaneous outbreaks of carbapenemase-producing enterobacteriaceae and extensively drug-resistant Acinetobacter baumannii infection in an intensive care unit using interventions promoted in the Centers for Disease Control and Prevention 2012 carbapenemase-resistant Enterobacteriaceae Toolkit.
    Enfield KB; Huq NN; Gosseling MF; Low DJ; Hazen KC; Toney DM; Slitt G; Zapata HJ; Cox HL; Lewis JD; Kundzins JR; Mathers AJ; Sifri CD
    Infect Control Hosp Epidemiol; 2014 Jul; 35(7):810-7. PubMed ID: 24915208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control strategy for carbapenemase-producing Enterobacteriaceae in nursing homes: perspectives inspired from three outbreaks.
    Legeay C; Hue R; Berton C; Cormier H; Chenouard R; Corvec S; Birgand G
    J Hosp Infect; 2019 Feb; 101(2):183-187. PubMed ID: 30389597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and epidemiological characterization of carbapenemase-producing Enterobacteriaceae in Norway, 2007 to 2014.
    Samuelsen Ø; Overballe-Petersen S; Bjørnholt JV; Brisse S; Doumith M; Woodford N; Hopkins KL; Aasnæs B; Haldorsen B; Sundsfjord A;
    PLoS One; 2017; 12(11):e0187832. PubMed ID: 29141051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementing a toolkit for the prevention, management and control of carbapenemase-producing Enterobacteriaceae in English acute hospitals trusts: a qualitative evaluation.
    Schneider A; Coope C; Michie S; Puleston R; Hopkins S; Oliver I
    BMC Health Serv Res; 2019 Oct; 19(1):689. PubMed ID: 31606053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of carbapenemase-producing Enterobacteriaceae in a pediatric hospital in a country with high endemicity.
    Castagnola E; Tatarelli P; Mesini A; Baldelli I; La Masa D; Biassoni R; Bandettini R
    J Infect Public Health; 2019; 12(2):270-274. PubMed ID: 30477920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics and costs of carbapenemase-producing enterobacteria carriers (2012/2013).
    Daroukh A; Delaunay C; Bigot S; Ceci JM; Siddhoun N; Bukreyeva I; Raisin J; Porcheret H; Maisonneuve L; Bouldouyre MA
    Med Mal Infect; 2014 Jul; 44(7):321-6. PubMed ID: 25022890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active case finding for carbapenemase-producing Enterobacteriaceae in a teaching hospital: prevalence and risk factors for colonization.
    Poole K; George R; Decraene V; Shankar K; Cawthorne J; Savage N; Welfare W; Dodgson A
    J Hosp Infect; 2016 Oct; 94(2):125-9. PubMed ID: 27542962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for carbapenem-resistant Enterobacteriaceae infections: a French case-control-control study.
    Nicolas-Chanoine MH; Vigan M; Laouénan C; Robert J;
    Eur J Clin Microbiol Infect Dis; 2019 Feb; 38(2):383-393. PubMed ID: 30488368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results from the Canadian Nosocomial Infection Surveillance Program on Carbapenemase-Producing Enterobacteriaceae, 2010 to 2014.
    Mataseje LF; Abdesselam K; Vachon J; Mitchel R; Bryce E; Roscoe D; Boyd DA; Embree J; Katz K; Kibsey P; Simor AE; Taylor G; Turgeon N; Langley J; Gravel D; Amaratunga K; Mulvey MR
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6787-6794. PubMed ID: 27600052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infection due to travel-related carbapenemase-producing Enterobacteriaceae, a largely underestimated phenomenon in Belgium.
    Jans B; D Huang TD; Bauraing C; Berhin C; Bogaerts P; Deplano A; Denis O; Catry B; Glupczynski Y
    Acta Clin Belg; 2015 Jun; 70(3):181-7. PubMed ID: 25825036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of carbapenemase-producing Enterobacteriaceae at the global and national level: what should be expected in the future?
    Oteo J; Miró E; Pérez-Vázquez M; Navarro F
    Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():17-23. PubMed ID: 25542048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergence of Carbapenemase-Producing Enterobacteriaceae, South-Central Ontario, Canada
    Kohler PP; Melano RG; Patel SN; Shafinaz S; Faheem A; Coleman BL; Green K; Armstrong I; Almohri H; Borgia S; Borgundvaag E; Johnstone J; Katz K; Lam F; Muller MP; Powis J; Poutanen SM; Richardson D; Rebbapragada A; Sarabia A; Simor A; McGeer A;
    Emerg Infect Dis; 2018 Sep; 24(9):1674-1682. PubMed ID: 30124197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The acceptability of screening for Carbapenemase Producing
    Currie K; King C; McAloney-Kocaman K; Roberts NJ; MacDonald J; Dickson A; Cairns S; Khanna N; Flowers P; Reilly J; Price L
    Antimicrob Resist Infect Control; 2018; 7():144. PubMed ID: 30534365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.